Neurocrine Biosciences Inc

LOOMIS SAYLES & CO L P NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

169,220

Value ($000)

24,000

Weight

0.0%

2014 Q1 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	24,000	0.0%	169,220	12/31/2025
2025 Q3	11/13/2025	22,575	0.0%	160,816	9/30/2025
2025 Q2	8/13/2025	17,657	0.0%	140,484	6/30/2025
2024 Q3	11/13/2024	17,322	0.0%	150,337	9/30/2024
2024 Q2	8/13/2024	22,064	0.0%	160,270	6/30/2024
2024 Q1	5/14/2024	35,160	0.1%	254,933	3/31/2024
2023 Q4	2/13/2024	33,713	0.1%	255,869	12/31/2023
2023 Q3	11/9/2023	28,904	0.0%	256,926	9/30/2023
2023 Q2	8/11/2023	19,533	0.0%	207,139	6/30/2023
2023 Q1	5/15/2023	16,499	0.0%	163,003	3/31/2023
2022 Q3	11/14/2022	203	0.0%	1,910	9/30/2022
2022 Q2	8/5/2022	200	0.0%	2,052	6/30/2022
2022 Q1	5/13/2022	191	0.0%	2,033	3/31/2022
2021 Q3	11/12/2021	25,930	0.0%	270,355	9/30/2021
2021 Q2	8/13/2021	25,578	0.0%	262,824	6/30/2021
2021 Q1	5/17/2021	24,555	0.0%	252,497	3/31/2021
2020 Q4	2/12/2021	24,165	0.0%	252,120	12/31/2020
2020 Q3	11/12/2020	19,559	0.0%	203,399	9/30/2020
2020 Q2	8/14/2020	22,632	0.0%	185,507	6/30/2020
2020 Q1	5/15/2020	14,812	0.0%	171,145	3/31/2020
2019 Q4	2/14/2020	18,694	0.0%	173,917	12/31/2019
2014 Q1	5/15/2014	13,996	0.0%	869,364	3/31/2014